MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Ustekinumab for the Treatment of Giant Cell Arteritis
Phase 1
Terminated
- Conditions
- Giant Cell ArteritisTemporal ArteritisHorton's Disease
- Interventions
- First Posted Date
- 2016-11-04
- Last Posted Date
- 2020-06-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 13
- Registration Number
- NCT02955147
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Impact of Weight Loss Surgery in Adolescents With NAFLD
Not Applicable
Completed
- Conditions
- NAFLDObesity, Adolescent
- Interventions
- Other: MRI
- First Posted Date
- 2016-11-02
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 11
- Registration Number
- NCT02952170
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation
Not Applicable
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Other: Baseline alert
- First Posted Date
- 2016-11-01
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 2336
- Registration Number
- NCT02950285
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
Not Applicable
Recruiting
- Conditions
- Barrett's Esophagus
- Interventions
- Device: Experimental OFDI Imaging
- First Posted Date
- 2016-10-28
- Last Posted Date
- 2024-05-13
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT02947971
- Locations
- 🇺🇸
Massachusetts General hospital, Boston, Massachusetts, United States
Pilot Study for Imaging of the Esophagus Using Tethered Capsule OCT Endomicroscopy With Distal Scanning
Completed
- Conditions
- Healthy
- Interventions
- Device: OFDI capsule
- First Posted Date
- 2016-10-28
- Last Posted Date
- 2023-01-17
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 4
- Registration Number
- NCT02947997
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Proton/Photon Rt - Benign Meningiomas(P92-13)
Phase 3
Completed
- Conditions
- Benign Meningioma
- Interventions
- Radiation: Standard TreatmentRadiation: Higher Dose
- First Posted Date
- 2016-10-28
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 44
- Registration Number
- NCT02947984
- Locations
- 🇺🇸
Massachusetts General Hosital, Boston, Massachusetts, United States
Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
Phase 4
Terminated
- Conditions
- Constipation
- Interventions
- Drug: MOVANTIK™ (naloxegol)Drug: Sugar Pill
- First Posted Date
- 2016-10-27
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 53
- Registration Number
- NCT02946580
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
Phase 4
Completed
- Conditions
- Renal Failure
- Interventions
- First Posted Date
- 2016-10-26
- Last Posted Date
- 2020-06-09
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT02945150
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C
Phase 4
Completed
- Conditions
- Chronic Kidney DiseaseChronic Hepatitis C
- Interventions
- Drug: Viekira Pak ± ribavirin
- First Posted Date
- 2016-10-26
- Last Posted Date
- 2021-11-05
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT02946034
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
- First Posted Date
- 2016-10-24
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT02943590
- Locations
- 🇺🇸
Massachusetts general Hospital, Boston, Massachusetts, United States
🇺🇸University of Pennsylvania Medical System, Philadelphia, Pennsylvania, United States
🇨🇦McGill University Health Center, Toronto, Canada